• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病患者高密度脂蛋白非酶糖基化的特征分析

Characterization of the non enzymatic glycation of high density lipoprotein in diabetic patients.

作者信息

Calvo C, Ponsin G, Berthezene F

机构信息

INSERM U 197, Laboratoire de Métabolisme des Lipides, Hôpital de l'Antiquaille, F-Lyon.

出版信息

Diabete Metab. 1988 May-Jun;14(3):264-9.

PMID:3137109
Abstract

In diabetic patients, hyperglycaemia results in the non enzymatic glycation of many proteins. We studied the glycation of HDL of patients with either type 1 or type 2 diabetes compared with that of control subjects. Although a basal glycation was detectable in HDL of normal individuals, this increased by about 400% in HDL of both groups of diabetic patients. The degree of HDL glycation was positively correlated with blood glucose concentration. All the HDL apoproteins were glycated but the glycation of apo A-I represented about 80% of the total HDL. These data were compared to those obtained in vitro after incubation of normal apo A-I either as free molecular species or as phospholipid/apo A-I complex, in the presence of glucose (0 to 80 mmol/l) at 37 degrees C. The resulting apo A-I glycation was dependent upon both time of incubation and glucose concentration and was largely increased in the presence of phospholipids. These data suggest that the in vivo glycation of HDL apoproteins might depend upon glucose concentration but might also be partly influenced by their lipid environment.

摘要

在糖尿病患者中,高血糖会导致许多蛋白质发生非酶糖基化。我们研究了1型或2型糖尿病患者高密度脂蛋白(HDL)的糖基化情况,并与对照组受试者进行了比较。虽然在正常个体的HDL中可检测到基础糖基化,但两组糖尿病患者HDL中的这种糖基化增加了约400%。HDL糖基化程度与血糖浓度呈正相关。所有HDL载脂蛋白都发生了糖基化,但载脂蛋白A-I(apo A-I)的糖基化约占HDL总糖基化的80%。将这些数据与在37℃下,正常apo A-I作为游离分子形式或磷脂/apo A-I复合物,在葡萄糖(0至80 mmol/L)存在下孵育后体外获得的数据进行比较。由此产生的apo A-I糖基化取决于孵育时间和葡萄糖浓度,并且在磷脂存在下大幅增加。这些数据表明,HDL载脂蛋白的体内糖基化可能取决于葡萄糖浓度,但也可能部分受其脂质环境的影响。

相似文献

1
Characterization of the non enzymatic glycation of high density lipoprotein in diabetic patients.糖尿病患者高密度脂蛋白非酶糖基化的特征分析
Diabete Metab. 1988 May-Jun;14(3):264-9.
2
Non enzymatic glycation of apolipoprotein A-I. Effects on its self-association and lipid binding properties.载脂蛋白A-I的非酶糖基化。对其自缔合及脂质结合特性的影响。
Biochem Biophys Res Commun. 1988 Jun 30;153(3):1060-7. doi: 10.1016/s0006-291x(88)81336-6.
3
The relationship of chemical modification of membrane proteins and plasma lipoproteins to reduced membrane fluidity of erythrocytes from diabetic subjects.糖尿病患者红细胞膜蛋白和血浆脂蛋白的化学修饰与膜流动性降低之间的关系。
Eur J Clin Chem Clin Biochem. 1992 Sep;30(9):513-9. doi: 10.1515/cclm.1992.30.9.513.
4
Lipoprotein composition in insulin-dependent diabetes mellitus with chronic renal failure: effect of kidney and pancreas transplantation.胰岛素依赖型糖尿病合并慢性肾衰竭患者的脂蛋白组成:肾移植和胰腺移植的影响
Metabolism. 1994 Mar;43(3):333-47. doi: 10.1016/0026-0495(94)90102-3.
5
Analysis of plasma lipids and apolipoproteins in insulin-dependent and noninsulin-dependent diabetics.胰岛素依赖型和非胰岛素依赖型糖尿病患者血浆脂质和载脂蛋白分析。
Metabolism. 1984 Jan;33(1):42-9. doi: 10.1016/0026-0495(84)90160-4.
6
Whole-plasma and high-density lipoprotein subfraction surface lipid composition in IDDM men.胰岛素依赖型糖尿病男性的全血浆和高密度脂蛋白亚组分表面脂质组成
Diabetes. 1989 Oct;38(10):1226-30. doi: 10.2337/diab.38.10.1226.
7
[Changes in the high-density lipoprotein level in patients with diabetes mellitus type II].[2型糖尿病患者高密度脂蛋白水平的变化]
Vutr Boles. 1990;29(3):89-92.
8
Nonenzymic glycation of apolipoprotein B in patients with insulin- and noninsulin-dependent diabetes mellitus.胰岛素依赖型和非胰岛素依赖型糖尿病患者载脂蛋白B的非酶糖基化
Clin Biochem. 1995 Dec;28(6):587-92. doi: 10.1016/0009-9120(95)00041-5.
9
Reactivity of lecithin-cholesterol acyl transferase (LCAT) towards glycated high-density lipoproteins (HDL).卵磷脂胆固醇酰基转移酶(LCAT)对糖化高密度脂蛋白(HDL)的反应性。
Clin Chim Acta. 1995 Jan 31;234(1-2):47-61. doi: 10.1016/0009-8981(94)05975-x.
10
Lysine glycation of apolipoprotein A-I impairs its anti-inflammatory function in type 2 diabetes mellitus.载脂蛋白 A-I 的赖氨酸糖基化会损害其在 2 型糖尿病中的抗炎功能。
J Mol Cell Cardiol. 2018 Sep;122:47-57. doi: 10.1016/j.yjmcc.2018.08.001. Epub 2018 Aug 7.

引用本文的文献

1
Lack of Neuroprotective Effects of High-Density Lipoprotein Therapy in Stroke under Acute Hyperglycemic Conditions.急性高血糖状态下,高密度脂蛋白治疗对卒中无神经保护作用。
Molecules. 2021 Oct 21;26(21):6365. doi: 10.3390/molecules26216365.
2
GlyStruct: glycation prediction using structural properties of amino acid residues.GlyStruct:基于氨基酸残基结构性质的糖化预测。
BMC Bioinformatics. 2019 Feb 4;19(Suppl 13):547. doi: 10.1186/s12859-018-2547-x.
3
Plasma oxidized high-density lipoprotein and glycated apolipoprotein A-I concentrations in ST-segment elevation myocardial infarction patients with stress hyperglycaemia or high thrombus burden.
应激性高血糖或血栓负荷高的 ST 段抬高型心肌梗死患者的血浆氧化高密度脂蛋白和糖化载脂蛋白 A-I 浓度。
Ups J Med Sci. 2018 Sep;123(3):158-166. doi: 10.1080/03009734.2018.1494229. Epub 2018 Sep 27.
4
Oxidized high-density lipoprotein is associated with increased plasma glucose in non-diabetic dyslipidemic subjects.氧化型高密度脂蛋白与非糖尿病血脂异常患者的血浆葡萄糖升高有关。
Clin Chim Acta. 2012 Dec 24;414:125-129. doi: 10.1016/j.cca.2012.08.021. Epub 2012 Sep 6.
5
The emerging role of HDL in glucose metabolism.HDL 在糖代谢中的新兴作用。
Nat Rev Endocrinol. 2012 Jan 24;8(4):237-45. doi: 10.1038/nrendo.2011.235.
6
Glycation isotopic labeling with 13C-reducing sugars for quantitative analysis of glycated proteins in human plasma.使用 13C-还原糖进行糖化同位素标记,用于定量分析人血浆中的糖化蛋白。
Mol Cell Proteomics. 2010 Mar;9(3):579-92. doi: 10.1074/mcp.M900439-MCP200. Epub 2009 Nov 6.
7
Dysfunctional HDL as a diagnostic and therapeutic target.功能失调的高密度脂蛋白作为诊断和治疗靶点。
Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):151-5. doi: 10.1161/ATVBAHA.108.179226. Epub 2009 Aug 13.
8
Why is HDL functionally deficient in type 2 diabetes?为什么2型糖尿病患者的高密度脂蛋白(HDL)功能存在缺陷?
Curr Diab Rep. 2008 Feb;8(1):51-9. doi: 10.1007/s11892-008-0010-5.
9
Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications.糖尿病中氨基脱氧葡萄糖修饰的糖化血清蛋白与动脉粥样硬化加速:发病机制及治疗意义
J Lab Clin Med. 2006 May;147(5):211-9. doi: 10.1016/j.lab.2005.12.006.